Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
NEW CRYSTAL FORM OF SODIUM-GLUCOSE CO-TRANSPORTER INHIBITOR MEDICINE AND PREPARATION METHOD AND USE THEREOF
Document Type and Number:
WIPO Patent Application WO/2017/202351
Kind Code:
A1
Abstract:
The present invention relates to a new crystal form of a sodium-glucose co-transporter inhibitor medicine (Sotagliflozin) and a preparation method and use thereof. In addition, the present invention relates to a pharmaceutical composition containing the new Sotagliflozin crystal form and a method of using the new Sotagliflozin crystal form and the pharmaceutical composition to treat diseases. The crystal form provided by the present invention has advantageous performances like good stability, relatively low hygroscopicity, exploitability and tractability of process, and the preparation method is simple, is low in cost, and has an important value on the optimization and development of the drug in the future.

Inventors:
CHEN MINHUA (CN)
ZHANG YANFENG (CN)
ZOU PO (CN)
LIU KAI (CN)
ZHANG XIAOYU (CN)
Application Number:
CN2017/085813
Publication Date:
November 30, 2017
Filing Date:
May 25, 2017
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
CRYSTAL PHARMACEUTICAL CO LTD (CN)
International Classes:
C07H15/14; A61K31/7028; A61P3/10; C07H1/06
Foreign References:
CN102112483A2011-06-29
CN102821764A2012-12-12
CN103458875A2013-12-18
US20110077212A12011-03-31
Other References:
See also references of EP 3466958A4
Attorney, Agent or Firm:
SUZHOU CREATOR PATENT & TRADEMARK AGENCY LTD. (CN)
Download PDF: